RIO DE JANEIRO, (Reuters) - Brazil's Fiocruz biomedical institute will seek approval for the Oxford University/AstraZeneca vaccine against COVID-19 with federal health regulator Anvisa on Jan.
The article Brazil to seek regulatory approval for AstraZeneca vaccine on Jan. 15 appeared first on Stabroek News.